09 May 2019
Convatec Group Plc (“Convatec”), a leading global medical products and technologies company, held its annual general meeting today.
Download Full Press Release
PDF
Enquiries
|
|
investorrelations@convatec.com |
|
John Crosse, VP Investor Relations |
+44 (0)7500 141435 |
|
Mark Reynolds, Director Investor Relations |
+44 (0)7551 036625 |
|
|
|
|
Bobby Leach, VP Group Corporate Affairs |
+44 (0)7770 842226 |
|
Finsbury |
+44 (0)207 2513801 |
Press Release
5/13/2022
Convatec Group Plc Annual Results 2018
Read more5/13/2022
2018 Annual Report & Accounts
Read more5/13/2022
Appointment of Chief Executive Officer
Read more5/13/2022
Board Changes
Read more5/13/2022
Results of Annual General Meeting
Read more5/13/2022
Convatec partners with EWMA to support Research Grants in 2019
Read more5/13/2022
Board Change
Read more5/13/2022
Beta Bionics and Convatec announce partnership to bring Unomedical infusion set portfolio to the iLet™ Bionic Pancreas System
Read more5/13/2022
Convatec Group Plc First Half Results 2019
Read more5/13/2022
John McAdam appointed Chairman of Convatec
Read more5/13/2022
Acquisition of Southlake Medical Supplies
Read more5/13/2022
